ABT vs EGAN · P/E 25, rev $44.33B vs P/E 68, rev $88.4M
Abbott Laboratories (ABT) versus eGain Corporation (EGAN) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
eGain Corporation (EGAN) is a software - application company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported EGAN revenue for 2025-06-30 was $88.4M. Net income was $32.3M. Revenue was up 293.7% from 2024-06-30 to 2025-06-30. EGAN currently screens at market cap $189.3M and trailing P/E 68.0.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. EGAN currently screens at market cap $189.3M and trailing P/E 68.0.
Not investment advice. Open the ABT and EGAN stock pages for the full models.
Not investment advice.